201 related articles for article (PubMed ID: 37012949)
1. Macrophage Activation Syndrome (MAS): A Case Report and Narrative Review.
Dilibe A; Ugoala OS; Evbayekha EO; Khalilullah MZ; Adabale OK; Poyser TA; Oriaifo OF; Olori UI; Aiwuyo HO
Cureus; 2023 Mar; 15(3):e35670. PubMed ID: 37012949
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults.
Shiga T; Nozaki Y; Tomita D; Kishimoto K; Hirooka Y; Kinoshita K; Funauchi M; Matsumura I
Front Immunol; 2021; 12():750114. PubMed ID: 34691064
[TBL] [Abstract][Full Text] [Related]
3. A Diagnostic Dilemma: Adult-Onset Still's Disease With Secondary Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome?
Parkash O; Anand AS; Shayuk M
J Med Cases; 2023 May; 14(5):179-183. PubMed ID: 37303972
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of secondary macrophage activation syndrome with emapalumab in a patient with newly diagnosed adult-onset Still's disease: case report and review of the literature.
Gabr JB; Liu E; Mian S; Pillittere J; Bonilla E; Banki K; Perl A
Ann Transl Med; 2020 Jul; 8(14):887. PubMed ID: 32793731
[TBL] [Abstract][Full Text] [Related]
5. Population Pharmacokinetics of the Anti-Interferon-Gamma Monoclonal Antibody Emapalumab: An Updated Analysis.
Brossard P; Laveille C
Rheumatol Ther; 2024 Jun; 11(3):869-880. PubMed ID: 38662147
[TBL] [Abstract][Full Text] [Related]
6. First report of a patient meeting criteria for both multisystem inflammatory syndrome in children and adult onset Still's disease.
Alexandri M; Patel J; Paul E; Coule LW
BMC Rheumatol; 2022 Dec; 6(1):87. PubMed ID: 36575537
[TBL] [Abstract][Full Text] [Related]
7. Cloak and dagger: the case for adult onset still disease and hemophagocytic lymphohistiocytosis.
Félix FH; Leal LK; Fontenele JB
Rheumatol Int; 2009 Jun; 29(8):973-4. PubMed ID: 19115058
[TBL] [Abstract][Full Text] [Related]
8. A Recurrent Case of Adult-onset Still's Disease with Concurrent Acalculous Cholecystitis and Macrophage Activation Syndrome/Hemophagocytic Lymphohistiocytosis Successfully Treated with Combination Immunosuppressive Therapy.
Arai Y; Ishikawa Y; Abe K; Kato Y; Abe D; Fujiwara M; Kita Y
Intern Med; 2021 Jun; 60(12):1955-1961. PubMed ID: 33518559
[TBL] [Abstract][Full Text] [Related]
9. A Challenging Case of Adult-Onset Still's Disease Complicated by Macrophage Activation Syndrome With Multiorgan Failure.
Mohamed A; K A Yasin A; Mohamed A; Elamin N; Mustafa S; Fadul A; Syed G; Al-Tikrity M
Cureus; 2023 Aug; 15(8):e43128. PubMed ID: 37692615
[TBL] [Abstract][Full Text] [Related]
10. [Assessment of MS-Score and HScore in timeliness of diagnosis of macrophage activation syndrome associated with adult-onset Still's disease].
Peng Z; Gao XM; Zhou S; Wu CY; Zhao JL; Xu D; Li MT; Peng JM; Li J; Wang Q; Tian XF; Zeng X
Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(28):2210-2214. PubMed ID: 35872586
[TBL] [Abstract][Full Text] [Related]
11. Adult macrophage activation syndrome-haemophagocytic lymphohistiocytosis: 'of plasma exchange and immunosuppressive escalation strategies' - a single centre reflection.
Lorenz G; Schul L; Schraml F; Riedhammer KM; Einwächter H; Verbeek M; Slotta-Huspenina J; Schmaderer C; Küchle C; Heemann U; Moog P
Lupus; 2020 Mar; 29(3):324-333. PubMed ID: 32013725
[TBL] [Abstract][Full Text] [Related]
12. Macrophage Activation Syndrome Versus Hemophagocytic Lymphohistiocytosis: A Diagnostic Dilemma in a Patient With Still's Disease and Epstein-Barr Virus Viremia.
Gomez R; Maakaron J; Baiocchi R
J Hematol; 2019 Jun; 8(2):68-70. PubMed ID: 32300447
[TBL] [Abstract][Full Text] [Related]
13. Mouse models of systemic juvenile idiopathic arthritis and macrophage activation syndrome.
Inoue N; Schulert GS
Arthritis Res Ther; 2023 Mar; 25(1):48. PubMed ID: 36964620
[TBL] [Abstract][Full Text] [Related]
14. Are the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome applicable to patients with adult-onset Still's disease?
Tada Y; Inokuchi S; Maruyama A; Suematsu R; Sakai M; Sadanaga Y; Ono N; Arinobu Y; Koarada S
Rheumatol Int; 2019 Jan; 39(1):97-104. PubMed ID: 30051293
[TBL] [Abstract][Full Text] [Related]
15. Hemophagocytic Lymphohistiocytosis Secondary to Adult-Onset Still's Disease.
Barman B; Jamil M; Kalita P; Dey B
Cureus; 2021 Sep; 13(9):e18037. PubMed ID: 34671525
[TBL] [Abstract][Full Text] [Related]
16. An atypical presentation of adult-onset Still's disease complicated by pulmonary hypertension and macrophage activation syndrome treated with immunosuppression: a case-based review of the literature.
Mehta MV; Manson DK; Horn EM; Haythe J
Pulm Circ; 2016 Mar; 6(1):136-42. PubMed ID: 27162622
[TBL] [Abstract][Full Text] [Related]
17. A Novel Therapy for a Rare Condition: Continuous Anakinra Infusion for a Patient With Macrophage Activation Syndrome.
Gullickson M; Nichols L; Scheibe M
Cureus; 2023 Aug; 15(8):e42968. PubMed ID: 37667692
[TBL] [Abstract][Full Text] [Related]
18. The Decimating Army: Hemophagocytic Lymphohistiocytosis as the Initial Presentation of Adult-Onset Still's Disease.
Agyeman WY; Waitimu S; Seffah KD; Allihien SM; Soleye S
Cureus; 2023 Aug; 15(8):e43875. PubMed ID: 37746424
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum gasdermin D N-terminal implicates monocyte and macrophage pyroptosis in adult-onset Still's disease.
Nagai H; Kirino Y; Nakano H; Kunishita Y; Henmi R; Szymanski AM; Yoshimi R; Ombrello MJ; Nakajima H
Rheumatology (Oxford); 2021 Aug; 60(8):3888-3895. PubMed ID: 33550379
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Moderately Dosed Etoposide in Macrophage Activation Syndrome-Hemophagocytic Lymphohistiocytosis.
Horne A; von Bahr Greenwood T; Chiang SCC; Meeths M; Björklund C; Ekelund M; Erensjö P; Berg S; Hagelberg S; Bryceson YT; Andersson U; Henter JI
J Rheumatol; 2021 Oct; 48(10):1596-1602. PubMed ID: 33589555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
